EGFR and metastatic neoplasm: IL‐6 then binds to IL‐6R on liver cancer cells, promoting their proliferation.[368] In colorectal cancer, CD68+ /EGFR+ macrophages do not affect overall survival, while the number of CD11b+ /EGFR+ myeloid cells is associated with poor prognosis in patients with metastatic diseases.